GENERAL TRENDS
Industry Outlook and Observations
U.S. healthcare services spending exceeds $3.5 trillion annually, with hospitals and ambulatory care services representing the majority of spend. Hospitals alone account for approximately 30%+ of total U.S. healthcare expenditures, while ambulatory services (including surgery centers, physician practices, and outpatient facilities) continue to grow as a share of overall care delivery.
Ambulatory care services now represent ~45–50% of total healthcare spending, driven by clinical advances, payer pressure, and patient preference. Ambulatory Surgery Centers (ASCs) remain one of the fastest-growing settings, with industry forecasts calling for ~5–7% annual growth through the late 2020s as procedures continue migrating out of inpatient settings.
Total U.S. healthcare spending is projected to grow at ~5–6% annually through 2030, outpacing GDP. Growth is supported by demographic tailwinds (aging population), rising utilization, and continued outpatient migration, partially offset by reimbursement pressure and labor cost inflation. Unlike many sectors, healthcare services demand is largely non-discretionary, with procedure volumes and utilization expected to remain resilient into 2026 and beyond, even in a slower macroeconomic environment.
Recent and Upcoming Trends
Outpatient Migration Accelerates
Hospitals and health systems continue shifting procedures toward ASCs, hospital outpatient departments (HOPDs), and specialized clinics, driven by lower cost of care, favorable payer economics, and improved patient experience. This trend is expected to continue into 2026+, benefiting operators with scaled ambulatory footprints.
Health System Financial Pressure Drives Strategic Action
Many hospitals exited 2025 still facing margin pressure from labor costs, payer mix, and reimbursement lag. As a result, systems are increasingly pursuing portfolio optimization, partnerships, and divestitures—particularly of non-core or standalone assets.
Investment in care coordination, revenue cycle management, staffing optimization, and analytics remains a priority as providers seek to improve throughput and profitability without compromising quality or outcomes.
Physician Alignment and Platformization
Health systems and private equity sponsors continue investing in platform models that aggregate physician practices and outpatient facilities to drive scale, referral capture, and operating leverage. Multi-site, specialty-focused platforms remain a core growth strategy.
M&A Catalysts
Fragmentation across care settings: The U.S. hospital market remains highly fragmented, with the top 10 health systems accounting for ~25% of total hospital admissions, while the majority of hospitals and outpatient facilities remain independently operated. Similarly, despite significant consolidation, independent ownership still represents a meaningful share of ASCs, supporting continued platform formation and roll-up activity.
Capital needs and balance sheet stress: Ongoing capital requirements (technology, facilities, staffing) are driving providers to seek strategic partners, minority investments, recapitalizations, and full exits.
Payer and reimbursement dynamics: Scale continues to matter as reimbursement pressure persists. Government payers (Medicare and Medicaid) account for ~55–60% of hospital revenue, limiting pricing flexibility and increasing the importance of commercial payer negotiations, geographic diversification, and service-line mix optimization.
Valuation support for quality assets: Despite broader sector pressure, assets with strong outpatient exposure continue to attract premium interest. ASCs typically generate EBITDA margins in the mid-20% range, materially higher than hospital inpatient margins, supporting sustained strategic and private equity demand for outpatient-heavy platforms.
M&A ACTIVITY
North American Healthcare Transaction Velocity
DEAL SPOTLIGHT
Date: March 2025
Target: ShorePoint Health Port Charlotte
Buyer: AdventHealth
Transaction Value: $260 Million
Strategic Fit:
The transaction enables AdventHealth to expand its Florida hospital footprint and enhance integrated care delivery across inpatient, outpatient, clinic, and emergency settings.
ShorePoint Health’s assets, including physician operations and an emergency department, complement AdventHealth’s existing network and support broader continuum-of-care strategies in a rapidly growing regional market.
Expected Outcome:
AdventHealth is expected to drive operational integration, improve access and care coordination, and leverage its scale to enhance clinical quality and financial performance metrics in Southwest Florida, positioning the combined operations to better meet community demand and support growth objectives.
Date: July 2025
Target: CHRISTUS Santa Rosa Medical Center (Medical Center Campus)
Buyer: University Health
Transaction Value: $71 Million
Strategic Fit:
The acquisition expands University Health’s inpatient and ambulatory care footprint in the South Texas Medical Center, enabling the system to decompress capacity at its flagship hospital and strategically repurpose the former CHRISTUS campus for a mix of specialty services, outpatient care, and diagnostic offerings.
Expected Outcome:
University Health plans to invest in renovations and equipment to transform the campus into a center for integrated care delivery, enhance patient access, support specialty and ambulatory services, and leverage existing infrastructure to accommodate growing community healthcare needs while containing capital intensity relative to new build projects.
CLICK HERE FOR 555 RELATED TRANSACTIONS
ABOUT 555 CAPITAL ADVISORS
Investment bank and advisory firm providing bespoke M&A, capital raise, and related services to middle market companies
Transactions: 100% Sale or Divestiture, Growth Capital, Recapitalizations, Mergers, Management Buyouts, Acquisition Advisory and Financing
Industries Served: Manufacturing, Business Services, Consumer, Technology, and Healthcare
Highly experienced and personalized client relationships: 25+ years experience, 100+ transactions, and mandates, customized solutions
The opinions expressed herein are those of 555 Capital Advisors. There is no guarantee that any predictions/projections as to certain market activity or events will come to fruition or past market or transaction performance referenced within will yield the same results as transactions previously conducted by 555 Capital Advisors.
Securities offered through Finalis Securities LLC Member FINRA & SIPC
This presentation contains information obtained from third parties, including but not limited to market data. 555 Capital Advisors believes such information to be accurate but has not independently verified such information. To the extent such information is obtained from third-party sources, there is a risk that the assumptions made and conclusions drawn by 555 Capital Advisors based on such representations are not accurate.
